Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a …

L Bodnar, G Wcislo, A Gasowska-Bodnar… - European Journal of …, 2008 - Elsevier
BACKGROUND: The aim of this study was to examine the effect of magnesium
supplementation on nephrotoxicity accompanying standard cisplatin-based chemotherapy …

[HTML][HTML] Prognostic significance of survivin expression in patients with ovarian carcinoma: A meta-analysis

B Gąsowska-Bajger, A Gąsowska-Bodnar… - Journal of clinical …, 2021 - mdpi.com
Background: Survivin belongs to the protein family of inhibitors of apoptosis (IAP) and is a
regulator of the cell cycle and apoptosis. The aim of this study was to assess the clinical and …

Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer

…, GB Wcislo, M Smoter, A Gasowska-Bodnar… - Kidney and Blood …, 2010 - karger.com
Aims: To evaluate the potential role of serum cystatin C as a marker of renal function in
patients with ovarian cancer. Methods: Treatment of consecutive ovarian cancer patients …

Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy

A Gąsowska-Bodnar, L Bodnar, A Dąbek… - International Journal of …, 2014 - ijgc.bmj.com
Background The aim of this study was to evaluate association of expression of survivin and
p53 with the effects of neoadjuvant chemotherapy (NAC) in patients with advanced ovarian …

Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature

W Baranowski, P Wiśniewski… - Ginekologia …, 2009 - journals.viamedica.pl
Background. Primary serous peritoneal psammocarcinoma (PSPP) is a rare variant of
serous carcinoma characterized by massive psammoma body formation and low-grade …

Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers

A Synowiec, G Wcisło, L Bodnar, C Szczylik… - Ginekologia …, 2014 - journals.viamedica.pl
Worldwide screening for early detection of ovarian cancer in both, the general population
and the group of women at high risk for ovarian cancer, including BRCA genes mutations …

[HTML][HTML] The Effect of Acetylsalicylic Acid, as a Representative Non-Steroidal Anti-Inflammatory Drug, on the Activity of Myeloperoxidase

B Gąsowska-Bajger, K Sosnowska… - Pharmaceuticals, 2023 - mdpi.com
Background: Acetylsalicylic acid (ASA or aspirin) is one of the world's most widely used non-
steroidal anti-inflammatory drug (NSAID). Numerous studies have shown that the long-term …

Salvage therapy with topotecan in heavily pretreated ovarian cancer patients

…, K Szarlej-Wcislo, A Gasowska-Bodnar… - Journal of cancer …, 2009 - Springer
Background We showed feasibility and efficacy of topotecan in third or a higher line of
chemotherapy in heavily pretreated ovarian cancer (HPOC) patients. Methods Between …

Properties and functions of myeloperoxidase and its role in ovarian cancer

B Gąsowska-Bajger, A Gąsowska-Bodnar… - Medical Science …, 2022 - ceeol.com
Background: Elevated levels of myeloperoxidase in body fluids are increasingly being used
as an indicator for the diagnosis of cancer. Aim of the study: The aim of this study was to …

[PDF][PDF] Serum TRAIL levels in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. A pilot study.

A Gasowska-Bodnar, L Bodnar… - Eur. J. Gynaec …, 2011 - article.imrpress.com
Aims: The study attempted to evaluate the kinetics of changes in serum TRAIL levels as a
potential predictive and prognostic factor in patients with epithelial ovarian cancer (EOC) or …